Logo image of HCO.PA

HIGH CO (HCO.PA) Stock Fundamental Analysis

EPA:HCO - Euronext Paris - Matif - FR0000054231 - Common Stock - Currency: EUR

3.2  -0.04 (-1.23%)

Fundamental Rating

6

Taking everything into account, HCO scores 6 out of 10 in our fundamental rating. HCO was compared to 66 industry peers in the Media industry. HCO scores excellent points on both the profitability and health parts. This is a solid base for a good stock. HCO is cheap, but on the other hand it scores bad on growth. Finally HCO also has an excellent dividend rating. This makes HCO very considerable for value and dividend investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year HCO was profitable.
In the past year HCO had a positive cash flow from operations.
HCO had positive earnings in each of the past 5 years.
Each year in the past 5 years HCO had a positive operating cash flow.
HCO.PA Yearly Net Income VS EBIT VS OCF VS FCFHCO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

1.2 Ratios

HCO has a Return On Assets of 5.37%. This is in the better half of the industry: HCO outperforms 75.76% of its industry peers.
The Return On Equity of HCO (12.11%) is better than 66.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.57%, HCO is in the better half of the industry, outperforming 71.21% of the companies in the same industry.
HCO had an Average Return On Invested Capital over the past 3 years of 8.81%. This is in line with the industry average of 8.90%.
Industry RankSector Rank
ROA 5.37%
ROE 12.11%
ROIC 8.57%
ROA(3y)3.8%
ROA(5y)3.37%
ROE(3y)8.66%
ROE(5y)8.21%
ROIC(3y)8.81%
ROIC(5y)8.3%
HCO.PA Yearly ROA, ROE, ROICHCO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 7.62%, HCO is in the better half of the industry, outperforming 74.24% of the companies in the same industry.
In the last couple of years the Profit Margin of HCO has grown nicely.
HCO has a Operating Margin of 10.96%. This is in the better half of the industry: HCO outperforms 71.21% of its industry peers.
In the last couple of years the Operating Margin of HCO has grown nicely.
HCO has a Gross Margin (42.84%) which is in line with its industry peers.
In the last couple of years the Gross Margin of HCO has grown nicely.
Industry RankSector Rank
OM 10.96%
PM (TTM) 7.62%
GM 42.84%
OM growth 3Y5.86%
OM growth 5Y4.97%
PM growth 3Y34.64%
PM growth 5Y8.98%
GM growth 3Y-2.23%
GM growth 5Y1.84%
HCO.PA Yearly Profit, Operating, Gross MarginsHCO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HCO is still creating some value.
Compared to 1 year ago, HCO has less shares outstanding
Compared to 5 years ago, HCO has less shares outstanding
Compared to 1 year ago, HCO has an improved debt to assets ratio.
HCO.PA Yearly Shares OutstandingHCO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
HCO.PA Yearly Total Debt VS Total AssetsHCO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 1.80, we must say that HCO is in the distress zone and has some risk of bankruptcy.
HCO has a Altman-Z score of 1.80. This is comparable to the rest of the industry: HCO outperforms 57.58% of its industry peers.
HCO has a debt to FCF ratio of 0.39. This is a very positive value and a sign of high solvency as it would only need 0.39 years to pay back of all of its debts.
HCO has a better Debt to FCF ratio (0.39) than 96.97% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that HCO is not too dependend on debt financing.
The Debt to Equity ratio of HCO (0.10) is better than 86.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.39
Altman-Z 1.8
ROIC/WACC1.24
WACC6.93%
HCO.PA Yearly LT Debt VS Equity VS FCFHCO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.3 Liquidity

HCO has a Current Ratio of 1.17. This is a normal value and indicates that HCO is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.17, HCO is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
A Quick Ratio of 1.17 indicates that HCO should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.17, HCO is in the better half of the industry, outperforming 69.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17
HCO.PA Yearly Current Assets VS Current LiabilitesHCO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

1

3. Growth

3.1 Past

HCO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 419.58%, which is quite impressive.
Measured over the past 5 years, HCO shows a small growth in Earnings Per Share. The EPS has been growing by 6.05% on average per year.
The Revenue has decreased by -2.67% in the past year.
HCO shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.50% yearly.
EPS 1Y (TTM)419.58%
EPS 3Y40.1%
EPS 5Y6.05%
EPS Q2Q%6.74%
Revenue 1Y (TTM)-2.67%
Revenue growth 3Y2.15%
Revenue growth 5Y-3.5%
Sales Q2Q%0.83%

3.2 Future

HCO is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -14.15% yearly.
Based on estimates for the next years, HCO will show a decrease in Revenue. The Revenue will decrease by -4.95% on average per year.
EPS Next Y-36.72%
EPS Next 2Y-23.1%
EPS Next 3Y-14.15%
EPS Next 5YN/A
Revenue Next Year-4.76%
Revenue Next 2Y-6.71%
Revenue Next 3Y-4.95%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HCO.PA Yearly Revenue VS EstimatesHCO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
HCO.PA Yearly EPS VS EstimatesHCO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 5.52 indicates a rather cheap valuation of HCO.
Based on the Price/Earnings ratio, HCO is valued cheaply inside the industry as 90.91% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.80, HCO is valued rather cheaply.
A Price/Forward Earnings ratio of 11.12 indicates a reasonable valuation of HCO.
HCO's Price/Forward Earnings is on the same level as the industry average.
HCO is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.91, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.52
Fwd PE 11.12
HCO.PA Price Earnings VS Forward Price EarningsHCO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

98.48% of the companies in the same industry are more expensive than HCO, based on the Enterprise Value to EBITDA ratio.
90.91% of the companies in the same industry are more expensive than HCO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.13
EV/EBITDA 0.42
HCO.PA Per share dataHCO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The decent profitability rating of HCO may justify a higher PE ratio.
A cheap valuation may be justified as HCO's earnings are expected to decrease with -14.15% in the coming years.
PEG (NY)N/A
PEG (5Y)0.91
EPS Next 2Y-23.1%
EPS Next 3Y-14.15%

7

5. Dividend

5.1 Amount

HCO has a Yearly Dividend Yield of 7.49%, which is a nice return.
Compared to an average industry Dividend Yield of 4.12, HCO pays a better dividend. On top of this HCO pays more dividend than 96.97% of the companies listed in the same industry.
HCO's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 7.49%

5.2 History

On average, the dividend of HCO grows each year by 20.62%, which is quite nice.
Dividend Growth(5Y)20.62%
Div Incr Years2
Div Non Decr Years2
HCO.PA Yearly Dividends per shareHCO.PA Yearly Dividends per shareYearly Dividends per share 2019 2021 2022 2023 2024 0 0 0 0 0

5.3 Sustainability

49.81% of the earnings are spent on dividend by HCO. This is a bit on the high side, but may be sustainable.
DP49.81%
EPS Next 2Y-23.1%
EPS Next 3Y-14.15%
HCO.PA Yearly Income VS Free CF VS DividendHCO.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
HCO.PA Dividend Payout.HCO.PA Dividend Payout, showing the Payout Ratio.HCO.PA Dividend Payout.PayoutRetained Earnings

HIGH CO

EPA:HCO (3/27/2025, 7:00:00 PM)

3.2

-0.04 (-1.23%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)10-16 2024-10-16
Earnings (Next)03-26 2025-03-26/amc
Inst Owners10.68%
Inst Owner ChangeN/A
Ins Owners15.88%
Ins Owner ChangeN/A
Market Cap65.47M
Analysts80
Price Target2.99 (-6.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.49%
Yearly Dividend0.48
Dividend Growth(5Y)20.62%
DP49.81%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.04%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)8.09%
Valuation
Industry RankSector Rank
PE 5.52
Fwd PE 11.12
P/S 0.45
P/FCF 2.13
P/OCF 2.05
P/B 0.71
P/tB 3.76
EV/EBITDA 0.42
EPS(TTM)0.58
EY18.12%
EPS(NY)0.29
Fwd EY9%
FCF(TTM)1.5
FCFY47.02%
OCF(TTM)1.56
OCFY48.75%
SpS7.14
BVpS4.49
TBVpS0.85
PEG (NY)N/A
PEG (5Y)0.91
Profitability
Industry RankSector Rank
ROA 5.37%
ROE 12.11%
ROCE 15.01%
ROIC 8.57%
ROICexc 24.08%
ROICexgc N/A
OM 10.96%
PM (TTM) 7.62%
GM 42.84%
FCFM 21.07%
ROA(3y)3.8%
ROA(5y)3.37%
ROE(3y)8.66%
ROE(5y)8.21%
ROIC(3y)8.81%
ROIC(5y)8.3%
ROICexc(3y)24.55%
ROICexc(5y)49.07%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.44%
ROCE(5y)14.55%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-45.91%
ROICexc growth 5Y-0.46%
OM growth 3Y5.86%
OM growth 5Y4.97%
PM growth 3Y34.64%
PM growth 5Y8.98%
GM growth 3Y-2.23%
GM growth 5Y1.84%
F-Score8
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.39
Debt/EBITDA 0.42
Cap/Depr 22.47%
Cap/Sales 0.77%
Interest Coverage 250
Cash Conversion 151.72%
Profit Quality 276.43%
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z 1.8
F-Score8
WACC6.93%
ROIC/WACC1.24
Cap/Depr(3y)23.97%
Cap/Depr(5y)27.84%
Cap/Sales(3y)0.96%
Cap/Sales(5y)1.26%
Profit Quality(3y)243.58%
Profit Quality(5y)274.05%
High Growth Momentum
Growth
EPS 1Y (TTM)419.58%
EPS 3Y40.1%
EPS 5Y6.05%
EPS Q2Q%6.74%
EPS Next Y-36.72%
EPS Next 2Y-23.1%
EPS Next 3Y-14.15%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.67%
Revenue growth 3Y2.15%
Revenue growth 5Y-3.5%
Sales Q2Q%0.83%
Revenue Next Year-4.76%
Revenue Next 2Y-6.71%
Revenue Next 3Y-4.95%
Revenue Next 5YN/A
EBIT growth 1Y80.41%
EBIT growth 3Y8.14%
EBIT growth 5Y1.3%
EBIT Next Year-7.89%
EBIT Next 3Y-5.08%
EBIT Next 5YN/A
FCF growth 1Y185.4%
FCF growth 3Y-12.98%
FCF growth 5Y-9.02%
OCF growth 1Y180.31%
OCF growth 3Y-13.02%
OCF growth 5Y-8.55%